Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2011 (2011), Article ID 316314, 6 pages
http://dx.doi.org/10.1155/2011/316314
Research Article

Expansion of CD16-Negative Natural Killer Cells in the Peripheral Blood of Patients with Metastatic Melanoma

1Division of Hematology, Department of Medicine, Mayo Clinic Graduate School of Medicine, 200 First Street SW, Rochester, MN 55905, USA
2Department of Oncology, Mayo Clinic Graduate School of Medicine, 200 First Street SW, Rochester, MN 55905, USA
3Department of Obstetrics and Gynecology, Mayo Clinic Graduate School of Medicine, 200 First Street SW, Rochester, MN 55905, USA
4Department of Immunology, Mayo Clinic Graduate School of Medicine, 200 First Street SW, Rochester, MN 55905, USA

Received 14 October 2010; Revised 17 December 2010; Accepted 17 January 2011

Academic Editor: Ronald Herberman

Copyright © 2011 Shernan G. Holtan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Shernan G. Holtan, Douglas J. Creedon, Michael A. Thompson, Wendy K. Nevala, and Svetomir N. Markovic, “Expansion of CD16-Negative Natural Killer Cells in the Peripheral Blood of Patients with Metastatic Melanoma,” Clinical and Developmental Immunology, vol. 2011, Article ID 316314, 6 pages, 2011. doi:10.1155/2011/316314